Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

A new study published in the New England Journal of Medicine reveals that medications widely used for diabetes and obesity ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

FAT jabs can treat a liver disease affecting one in five people, a trial found. Semaglutide cut inflammation in two thirds of ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

A study has found that Ozempic may reverse signs of a disease that contributes to 2,000,000 deaths per year. New research has ...

There could be a new use for semaglutide, the main ingredient of weight loss and diabetes drugs Wegovy and Ozempic. Dr. Jon ...